Płaskonabłonkowy rak skóry
Leczenie

Płaskonabłonkowy rak skóry (SCC) stanowi drugi co do częstości nowotwór skóry, z wysokim potencjałem wyleczenia przy wczesnym rozpoznaniu i odpowiednio dobranym leczeniu. Standardem terapii jest chirurgiczne usunięcie zmiany, z metodami dostosowanymi do ryzyka i lokalizacji guza: proste wycięcie z marginesem 4-6 mm dla zmian niskiego ryzyka, chirurgia mikrograficzna Mohsa dla SCC wysokiego ryzyka (wskaźnik wyleczenia do 97-99%), a także łyżeczkowanie z elektrodesykacją i kriochirurgia dla powierzchownych zmian. Radioterapia jest wskazana w przypadkach niekwalifikujących się do zabiegu chirurgicznego, obejmując leczenie uzupełniające i guzy z naciekaniem nerwów, realizowana zwykle w seriach przez 4-6 tygodni. Leczenie miejscowe obejmuje 5-fluorouracyl i imikwimod, stosowane głównie w SCC in situ, a terapia fotodynamiczna (PDT) jest efektywna w powierzchownych postaciach, zwłaszcza na twarzy i skórze głowy, oferując dobre efekty kosmetyczne.

Leczenie płaskonabłonkowego raka skóry

Płaskonabłonkowy rak skóry (SCC) jest drugim co do częstości występowania nowotworem skóry, stanowiącym istotny problem zdrowotny, szczególnie u osób starszych. Wczesne wykrycie i odpowiednio dobrane leczenie dają wysokie szanse na całkowite wyleczenie. Strategia terapeutyczna zależy od wielu czynników, w tym wielkości i lokalizacji guza, stopnia zaawansowania, tempa wzrostu oraz ogólnego stanu zdrowia pacjenta.12

Leczenie chirurgiczne

Chirurgiczne usunięcie zmiany jest najczęściej stosowaną i najbardziej skuteczną metodą leczenia płaskonabłonkowego raka skóry. Większość przypadków SCC można skutecznie wyleczyć przy zastosowaniu minimalnie inwazyjnych procedur chirurgicznych.34

  • Proste wycięcie chirurgiczne (excision) – metoda stosowana przy mniejszych zmianach, polegająca na wycięciu guza wraz z marginesem zdrowej tkanki (zazwyczaj 4-6 mm dla zmian niskiego ryzyka). Usunięty materiał jest badany histopatologicznie w celu potwierdzenia całkowitego usunięcia komórek nowotworowych.56
  • Chirurgia mikrograficzna Mohsa (Mohs micrographic surgery) – złoty standard w leczeniu SCC wysokiego ryzyka. Technika ta polega na warstwowym usuwaniu tkanki nowotworowej z jednoczesną mikroskopową kontrolą marginesów wycięcia. Zapewnia najwyższy wskaźnik wyleczenia (do 97-99% dla guzów leczonych po raz pierwszy) przy maksymalnym oszczędzeniu zdrowej tkanki. Jest szczególnie zalecana dla nowotworów zlokalizowanych w miejscach wrażliwych (twarz, uszy, skóra głowy, genitalia) oraz dla guzów nawrotowych lub o nieostrych granicach.789
  • Łyżeczkowanie i elektrodesykacja (curettage and electrodesiccation) – procedura, w której guz jest zeskrobywany przy użyciu specjalnego narzędzia (łyżeczki), a następnie obszar ten jest poddawany elektrokoagulacji w celu zniszczenia pozostałych komórek nowotworowych i zatrzymania krwawienia. Metoda ta jest odpowiednia głównie dla małych, powierzchownych SCC o niskim ryzyku nawrotu.1011
  • Kriochirurgia (cryosurgery) – polega na zastosowaniu ekstremalnie niskiej temperatury (zazwyczaj ciekłego azotu) do zamrożenia i zniszczenia tkanki nowotworowej. Jest to metoda odpowiednia dla powierzchownych SCC, zwłaszcza u pacjentów z zaburzeniami krzepnięcia, wszczepionymi urządzeniami kardiologicznymi lub problemami z tolerancją znieczulenia.1213

Radioterapia

Radioterapia stanowi wartościową opcję terapeutyczną w przypadku płaskonabłonkowego raka skóry, szczególnie gdy leczenie chirurgiczne jest trudne do przeprowadzenia lub przeciwwskazane. Polega na wykorzystaniu wysokoenergetycznego promieniowania do niszczenia komórek nowotworowych.1415

Wskazania do zastosowania radioterapii w leczeniu SCC obejmują:1617

  • Guzy, których nie można usunąć chirurgicznie
  • Pacjentów niekwalifikujących się do zabiegu chirurgicznego ze względu na wiek lub stan zdrowia
  • Zmiany zlokalizowane w miejscach trudnych do leczenia chirurgicznego (np. powieki, uszy, nos)
  • Leczenie uzupełniające po operacji, gdy istnieje ryzyko pozostawienia komórek nowotworowych
  • Przypadki naciekania nerwów przez nowotwór
  • Nowotwory wysokiego ryzyka

Radioterapia zwykle wymaga kilku sesji rozłożonych w czasie (często przez 4-6 tygodni) i może być stosowana samodzielnie lub w połączeniu z innymi metodami leczenia.18

Leczenie miejscowe

Leki stosowane miejscowo mogą być odpowiednią opcją terapeutyczną dla niektórych przypadków płaskonabłonkowego raka skóry, zwłaszcza w postaci powierzchownej (SCC in situ, choroba Bowena) lub jako alternatywa dla pacjentów niekwalifikujących się do innych metod leczenia.1920

  • 5-fluorouracyl (5-FU) – lek chemioterapeutyczny stosowany miejscowo, skuteczny w leczeniu powierzchownych form SCC. Działa poprzez blokowanie produkcji DNA i RNA w komórkach nowotworowych.2122
  • Imikwimod – modulator odpowiedzi immunologicznej, który stymuluje układ odpornościowy do walki z komórkami nowotworowymi. Stosowany głównie w leczeniu SCC in situ i powierzchownych zmian.2324

Leczenie miejscowe zazwyczaj wymaga regularnego stosowania przez kilka tygodni. Podczas terapii może wystąpić miejscowy stan zapalny skóry, który zazwyczaj ustępuje po zakończeniu leczenia.25

Terapia fotodynamiczna

Terapia fotodynamiczna (PDT) jest nieinwazyjną metodą leczenia niektórych przypadków płaskonabłonkowego raka skóry, zwłaszcza w postaci SCC in situ. Polega na zastosowaniu substancji fotouczulającej (najczęściej kwasu 5-aminolewulinowego lub jego pochodnych), która jest selektywnie gromadzona przez komórki nowotworowe, a następnie aktywowana światłem o określonej długości fali, co prowadzi do zniszczenia tych komórek.2627

PDT jest szczególnie przydatna w leczeniu powierzchownych SCC na twarzy i skórze głowy, ale nie jest zalecana dla inwazyjnych form SCC. Metoda ta oferuje dobre efekty kosmetyczne i może być stosowana w obszarach, gdzie inne metody mogą powodować znaczne blizny.2829

Leczenie zaawansowanego płaskonabłonkowego raka skóry

Zaawansowany płaskonabłonkowy rak skóry, obejmujący przypadki miejscowo zaawansowane, nawrotowe lub z przerzutami, wymaga bardziej złożonego podejścia terapeutycznego, często angażującego wielodyscyplinarny zespół specjalistów.3031

Immunoterapia

W ostatnich latach immunoterapia stała się przełomową opcją leczenia dla pacjentów z zaawansowanym płaskonabłonkowym rakiem skóry. Leki immunoterapeutyczne pomagają układowi odpornościowemu pacjenta rozpoznać i zniszczyć komórki nowotworowe.3233

Obecnie zatwierdzone leki immunoterapeutyczne w leczeniu zaawansowanego SCC to:343536

  • Cemiplimab (Libtayo) – inhibitor PD-1, zatwierdzony do leczenia zaawansowanego SCC, w tym miejscowo zaawansowanego SCC nieoperacyjnego lub z przerzutami. Jest to pierwszy lek immunoterapeutyczny zatwierdzony specjalnie do leczenia płaskonabłonkowego raka skóry.
  • Pembrolizumab (Keytruda) – inhibitor PD-1, stosowany w leczeniu nawrotowego lub przerzutowego SCC, który nie kwalifikuje się do leczenia chirurgicznego lub radioterapii.
  • Kosibelimab (Unloxcyt) – nowszy lek immunoterapeutyczny dołączony do opcji terapeutycznych dla zaawansowanego SCC.

Immunoterapia wykazuje obiecujące wyniki u około 50% pacjentów z zaawansowanym lub przerzutowym SCC, dając nadzieję pacjentom, dla których wcześniej opcje leczenia były ograniczone.3738

Terapia celowana

Terapia celowana wykorzystuje leki, które oddziałują na specyficzne cząsteczki lub mechanizmy komórkowe istotne dla wzrostu i przetrwania komórek nowotworowych. W przypadku płaskonabłonkowego raka skóry, szczególnie zaawansowanego, stosowane są inhibitory receptora naskórkowego czynnika wzrostu (EGFR).3940

Najczęściej stosowanym lekiem z tej grupy jest cetuksymab (Erbitux), który wiąże się z receptorem EGFR, blokując sygnały stymulujące wzrost guza. Jest szczególnie przydatny w przypadkach SCC, których nie można usunąć chirurgicznie lub leczyć radioterapią.4142

Chemioterapia systemowa

Chemioterapia systemowa jest zazwyczaj zarezerwowana dla zaawansowanych przypadków płaskonabłonkowego raka skóry z przerzutami, gdzie inne metody leczenia nie są skuteczne. Polega na podawaniu leków przeciwnowotworowych, które niszczą komórki rakowe lub hamują ich wzrost.4344

Najczęściej stosowane leki chemioterapeutyczne w leczeniu zaawansowanego SCC obejmują:4546

  • Cisplatyna – podstawowy lek chemioterapeutyczny w leczeniu przerzutowego SCC
  • 5-fluorouracyl (5-FU) – stosowany zarówno miejscowo, jak i ogólnoustrojowo
  • Doksorubicyna – może być stosowana w schematach leczenia zaawansowanego SCC
  • Kapecytabina – doustny lek przeciwnowotworowy

Chemioterapia może być stosowana samodzielnie lub w połączeniu z innymi metodami leczenia, takimi jak immunoterapia lub radioterapia. Jest jednak obarczona większym ryzykiem działań niepożądanych niż inne formy terapii.47

Leczenie dostosowane do pacjenta

Wybór optymalnej metody leczenia płaskonabłonkowego raka skóry powinien być zindywidualizowany i uwzględniać szereg czynników, takich jak:4849

  • Klasyfikacja guza jako niskiego lub wysokiego ryzyka
  • Lokalizacja anatomiczna zmiany
  • Wielkość i głębokość nacieku guza
  • Stan marginesów chirurgicznych
  • Obecność naciekania nerwów (inwazja okołonerwowa)
  • Stan układu odpornościowego pacjenta
  • Wiek i ogólny stan zdrowia pacjenta
  • Preferencje pacjenta

Podejście wielodyscyplinarne

W przypadku zaawansowanego płaskonabłonkowego raka skóry zalecane jest podejście wielodyscyplinarne, angażujące różnych specjalistów, takich jak dermatolog, chirurg, onkolog, radioterapeuta i patolog. Zespołowe podejście umożliwia opracowanie kompleksowego planu leczenia dostosowanego do indywidualnych potrzeb pacjenta.5051

Kombinacja różnych metod leczenia może być konieczna w przypadkach złożonych, np. chirurgiczne usunięcie guza z uzupełniającą radioterapią lub immunoterapią w celu zwiększenia skuteczności leczenia i zapobiegania nawrotom.5253

Obserwacja i profilaktyka

Po zakończeniu leczenia płaskonabłonkowego raka skóry konieczna jest regularna obserwacja pacjenta w celu wczesnego wykrycia ewentualnych nawrotów lub nowych ognisk nowotworu. Częstotliwość badań kontrolnych zależy od ryzyka nawrotu i powinna być ustalona indywidualnie.5455

Profilaktyka po leczeniu SCC obejmuje:5657

  • Regularne kontrole dermatologiczne z dokładnym badaniem skóry
  • Samobadanie skóry
  • Unikanie nadmiernej ekspozycji na promieniowanie UV
  • Codzienna ochrona przeciwsłoneczna (filtry UV, odzież ochronna)
  • Rozważenie suplementacji witaminą B3 (nikotynamid) w dawce 1000 mg dziennie, która może zmniejszyć ryzyko rozwoju nowych nowotworów skóry o około 23%
  • Leczenie rogowacenia słonecznego, które może zmniejszyć ryzyko rozwoju SCC

Badania kliniczne i nowe kierunki leczenia

Badania kliniczne odgrywają kluczową rolę w rozwoju nowych metod leczenia płaskonabłonkowego raka skóry. Pacjenci z zaawansowanym SCC lub opornym na standardowe leczenie mogą odnieść korzyści z udziału w badaniach klinicznych, które oferują dostęp do innowacyjnych terapii.5859

Obiecujące kierunki badań obejmują:606162

  • Nowe leki immunoterapeutyczne i kombinacje istniejących leków
  • Identyfikacja biomarkerów predykcyjnych dla odpowiedzi na immunoterapię
  • Terapie wykorzystujące lasery frakcyjne w połączeniu z lekami miejscowymi
  • Blokowanie szlaku JAK/STAT, co może być szczególnie korzystne dla pacjentów po przeszczepach narządów
  • Zastosowanie szczepionki przeciwko HPV w leczeniu i zapobieganiu nawrotom SCC u pacjentów nienadających się do leczenia chirurgicznego
  • Nowe metody radioterapii, takie jak elektronowa brachyterapia powierzchni skóry (ESSB)

Rozwój nowych, mniej inwazyjnych metod leczenia ma na celu poprawę skuteczności terapii przy jednoczesnym zmniejszeniu działań niepożądanych i poprawie jakości życia pacjentów z płaskonabłonkowym rakiem skóry.63

Podsumowanie

Płaskonabłonkowy rak skóry jest w większości przypadków nowotworem o dobrym rokowaniu, pod warunkiem wczesnego wykrycia i właściwego leczenia. Dostępne metody terapeutyczne obejmują leczenie chirurgiczne (złoty standard), radioterapię, leczenie miejscowe, terapię fotodynamiczną, a w przypadkach zaawansowanych – immunoterapię, terapię celowaną i chemioterapię systemową.6465

Wybór optymalnej metody leczenia powinien być zindywidualizowany i uwzględniać szereg czynników, takich jak stadium nowotworu, lokalizacja, wielkość, charakterystyka histopatologiczna oraz stan ogólny pacjenta. Podejście wielodyscyplinarne jest szczególnie istotne w przypadkach zaawansowanych.6667

Regularne badania kontrolne po zakończeniu leczenia oraz przestrzeganie zasad profilaktyki przeciwsłonecznej mają kluczowe znaczenie dla wczesnego wykrycia ewentualnych nawrotów i zapobiegania rozwojowi nowych nowotworów skóry.68

Postęp w badaniach nad nowymi metodami leczenia, szczególnie w obszarze immunoterapii i terapii celowanych, daje nadzieję na dalszą poprawę wyników leczenia pacjentów z płaskonabłonkowym rakiem skóry, zwłaszcza w przypadkach zaawansowanych lub opornych na leczenie.6970

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Squamous cell carcinoma of the skin – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/diagnosis-treatment/drc-20352486
    Most squamous cell carcinomas of the skin can be removed with minor surgery. Some are removed with a medicine applied to the skin. The treatment depends on where the cancer is, how large it is, how fast it’s growing and what you prefer. […] If the skin cancer is small, not deep into the skin, called superficial, and has a low risk of spreading, less-invasive treatment choices include: […] More-invasive treatments might be recommended for larger squamous cell carcinomas and those that go deeper into the skin. Options might include: […] When squamous cell carcinoma spreads to other parts of the body, medicines might be recommended, including: […] For squamous cell carcinoma of the skin, immunotherapy might be considered when the cancer is advanced and other treatments aren’t an option.
  • #2 Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/scc-treatment-options/
    Most squamous cell carcinomas (SCCs) of the skin can be cured when found and treated early. Treatment should happen as soon as possible after diagnosis, since more advanced SCCs of the skin are more difficult to treat and can become dangerous, spreading to local lymph nodes, distant tissues and organs. […] If you’ve been diagnosed with an SCC that has not spread (in situ), there are several effective treatments that can usually be performed on an outpatient basis. The choices available to you depend on the tumor type, size, location and depth, as well as your age and overall health. […] Options include: Excisional surgery, Mohs surgery, Cryosurgery, Curettage and electrodesiccation (electrosurgery), Laser surgery, Radiation, Photodynamic therapy (PDT), Topical medications. […] Ask your dermatologist to clearly explain the options that might work best for you, including details about the risks and benefits.
  • #3 Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/scc-treatment-options/
    For small, early SCCs that have not spread, excisional surgery is frequently the only treatment required. […] Mohs surgery is the most effective technique for removing SCCs, sparing the greatest amount of healthy tissue while achieving the highest possible cure rate – up to 97 percent for tumors treated for the first time. […] Curettage and electrodesiccation can be effective for most small, superficial or minimally invasive SCCs. […] Cryosurgery is effective for superficial SCCs, especially for patients with bleeding disorders, implantable cardiac devices or problems tolerating anesthesia. […] Laser surgery is not yet FDA-approved for SCC but is sometimes used for superficial SCCs, especially when other techniques have been unsuccessful. […] Radiation therapy is primarily used for SCCs that are hard to treat surgically, and in elderly patients or people in poor health for whom surgery is not advised. […] PDT can be used for some superficial SCCs on the face and scalp but is not recommended for invasive SCCs. […] While these topical medications are not yet FDA-approved for treating SCCs, they are sometimes used for superficial tumors.
  • #4 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    Treatment options for squamous cell cancer (SCC) of the skin depend on the risk of the cancer coming back, which is based on factors like the size and location of the tumor and how the cancer cells look under a microscope, as well as if a person has a weakened immune system. […] Most SCCs are found and treated at an early stage, when they can be removed or destroyed with local treatments such as surgery or radiation therapy. Small SCCs can usually be cured with these treatments. Larger SCCs are harder to treat, and fast-growing cancers have a higher risk of coming back. […] While its not common, SCC can sometimes spread to lymph nodes or distant parts of the body. If this happens, treatments such as radiation therapy, immunotherapy, and/or chemotherapy may be needed. […] Different types of surgery can be used to treat squamous cell skin cancers (SCCs).
  • #5 Guidelines of care for the management of cutaneous squamous cell carcinoma
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6652228/
    Given the limited available data, the work group recommends standard excision with a 4-to 6-mm margin of uninvolved skin around the tumor and/or biopsy site to a depth of the mid-subcutaneous adipose tissue with histologic margin assessment for low-risk primary cSCC (on the basis of NCCN risk stratification). Standard excision may be considered for select high-risk tumors. […] MMS is recommended for high-risk cSCC. […] CE is regularly used in daily practice for the treatment of low-risk cSCC. However, no RCTs have been performed and no prospective data are available to compare CE with other treatment modalities. […] Although surgery remains the first-line, and most effective, treatment for cSCC, primary radiation therapy can be used in special situations in which surgery is not feasible, contraindicated, or not preferred by the patient after a discussion of risks and benefits. […] The recommendations for management of regional and distant metastatic SCC are shown in Table XII, and the level of evidence/strength of the recommendation is provided in Table XIII.
  • #6 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Surgical excision removes the cancer along with some normal tissue around it (called the surgical margin). It is a common treatment for most types of SCC. […] Mohs surgery removes the cancer in layers, little by little, until no cancer remains. It is mainly done for high-risk SCC or SCC that comes back after treatment (called recurrent SCC). It can also be used when SCC could not be completely removed by surgical excision. Mohs surgery is often used for cancers with a border that is uneven, especially on the face, hands or feet. […] Curettage and electrodesiccation (CE) uses a sharp tool (called a curette) to scrape the cancer and remove it from the body. Then the area is treated with an electrical current to destroy any remaining cancer cells. It is commonly used for low-risk SCC, including SCC in situ.
  • #7 Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/scc-treatment-options/
    For small, early SCCs that have not spread, excisional surgery is frequently the only treatment required. […] Mohs surgery is the most effective technique for removing SCCs, sparing the greatest amount of healthy tissue while achieving the highest possible cure rate – up to 97 percent for tumors treated for the first time. […] Curettage and electrodesiccation can be effective for most small, superficial or minimally invasive SCCs. […] Cryosurgery is effective for superficial SCCs, especially for patients with bleeding disorders, implantable cardiac devices or problems tolerating anesthesia. […] Laser surgery is not yet FDA-approved for SCC but is sometimes used for superficial SCCs, especially when other techniques have been unsuccessful. […] Radiation therapy is primarily used for SCCs that are hard to treat surgically, and in elderly patients or people in poor health for whom surgery is not advised. […] PDT can be used for some superficial SCCs on the face and scalp but is not recommended for invasive SCCs. […] While these topical medications are not yet FDA-approved for treating SCCs, they are sometimes used for superficial tumors.
  • #8 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    Curettage and electrodesiccation: This approach might be useful in treating some small, thin SCCs that have a low risk of coming back, but its not usually used for larger tumors. […] Standard excision: This type of surgery, in which the tumor and a margin of normal skin around it are removed, is often used to treat SCCs. […] Mohs surgery is especially useful for SCCs that are at higher risk for coming back, such as larger tumors, tumors with poorly defined edges, cancers that have come back after other treatments, cancers that are spreading along nerves under the skin, and cancers on certain areas of the face or genital area. […] Radiation therapy might be an option for people with large SCCs, especially for tumors in areas where surgery would be hard to do (such as the eyelids, ears, or nose), or for people who cant have (or dont want) surgery.
  • #9 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Surgical excision removes the cancer along with some normal tissue around it (called the surgical margin). It is a common treatment for most types of SCC. […] Mohs surgery removes the cancer in layers, little by little, until no cancer remains. It is mainly done for high-risk SCC or SCC that comes back after treatment (called recurrent SCC). It can also be used when SCC could not be completely removed by surgical excision. Mohs surgery is often used for cancers with a border that is uneven, especially on the face, hands or feet. […] Curettage and electrodesiccation (CE) uses a sharp tool (called a curette) to scrape the cancer and remove it from the body. Then the area is treated with an electrical current to destroy any remaining cancer cells. It is commonly used for low-risk SCC, including SCC in situ.
  • #10 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    Curettage and electrodesiccation: This approach might be useful in treating some small, thin SCCs that have a low risk of coming back, but its not usually used for larger tumors. […] Standard excision: This type of surgery, in which the tumor and a margin of normal skin around it are removed, is often used to treat SCCs. […] Mohs surgery is especially useful for SCCs that are at higher risk for coming back, such as larger tumors, tumors with poorly defined edges, cancers that have come back after other treatments, cancers that are spreading along nerves under the skin, and cancers on certain areas of the face or genital area. […] Radiation therapy might be an option for people with large SCCs, especially for tumors in areas where surgery would be hard to do (such as the eyelids, ears, or nose), or for people who cant have (or dont want) surgery.
  • #11 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Surgical excision removes the cancer along with some normal tissue around it (called the surgical margin). It is a common treatment for most types of SCC. […] Mohs surgery removes the cancer in layers, little by little, until no cancer remains. It is mainly done for high-risk SCC or SCC that comes back after treatment (called recurrent SCC). It can also be used when SCC could not be completely removed by surgical excision. Mohs surgery is often used for cancers with a border that is uneven, especially on the face, hands or feet. […] Curettage and electrodesiccation (CE) uses a sharp tool (called a curette) to scrape the cancer and remove it from the body. Then the area is treated with an electrical current to destroy any remaining cancer cells. It is commonly used for low-risk SCC, including SCC in situ.
  • #12 Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/scc-treatment-options/
    For small, early SCCs that have not spread, excisional surgery is frequently the only treatment required. […] Mohs surgery is the most effective technique for removing SCCs, sparing the greatest amount of healthy tissue while achieving the highest possible cure rate – up to 97 percent for tumors treated for the first time. […] Curettage and electrodesiccation can be effective for most small, superficial or minimally invasive SCCs. […] Cryosurgery is effective for superficial SCCs, especially for patients with bleeding disorders, implantable cardiac devices or problems tolerating anesthesia. […] Laser surgery is not yet FDA-approved for SCC but is sometimes used for superficial SCCs, especially when other techniques have been unsuccessful. […] Radiation therapy is primarily used for SCCs that are hard to treat surgically, and in elderly patients or people in poor health for whom surgery is not advised. […] PDT can be used for some superficial SCCs on the face and scalp but is not recommended for invasive SCCs. […] While these topical medications are not yet FDA-approved for treating SCCs, they are sometimes used for superficial tumors.
  • #13 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Cryosurgery uses extreme cold to freeze and destroy tissue. It is often used to treat small tumours on the surface of the skin with clear and smooth borders, such as SCC in situ. It is usually offered when other types of surgery cant be done. […] A skin graft or a skin flap may be done to repair the skin and nearby area after SCC is removed. Skin from another area of the body is removed and placed over the surgical area to cover the open wound and repair the skin. It may be done if a large area of skin is removed to make sure the cancer is completely gone. […] A lymph node dissection removes lymph nodes from the body. It is not done very often, but may be offered for SCC that has spread to lymph nodes. Imaging tests or a physical exam will be done to see which lymph nodes need to be removed.
  • #14 Skin cancer types: Squamous cell carcinoma treatment
    https://www.aad.org/diseases/skin-cancer/squamous-cell-carcinoma-treatment
    Squamous cell skin cancer is highly treatable when found early. A board-certified dermatologist can often treat early squamous cell skin cancer in the office. […] Most skin cancers are treated with surgical removal of the cancer. Your dermatologist can often perform this type of treatment during an office visit. […] The following describes what to expect from surgical removal and other treatments for this skin cancer: Surgical removal: Three types of surgical removal are used to treat this type of skin cancer. All can be performed during an office visit while you remain awake. This surgery begins with your dermatologist using a local anesthetic to numb the area. […] Radiation therapy: If surgical removal alone cannot treat the cancer or you cannot have surgical removal, your treatment plan may include radiation treatments.
  • #15 Treatment for Squamous Cell Carcinoma | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/squamous-cell-carcinoma/treatment-squamous-cell-carcinoma
    This very common treatment for squamous cell carcinoma is most effective for low-risk tumors. […] Radiation therapy with x-rays or high-energy particles can be useful for treating tumors in areas that are difficult to treat with surgery, or in older people and others at a higher risk for complications with surgery. […] Some skin cancers that do not require very deep radiation may be treated with a new form of radiation therapy applied directly to the skin, called electronic skin surface brachytherapy (ESSB).
  • #16 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Radiation therapy uses high-energy rays or particles to destroy cancer cells. You may be offered radiation therapy to: treat SCC that cant be removed with surgery or if surgery will change your appearance or how the area functions, treat SCC that could not be completely removed by surgery, after surgery to destroy cancer cells that have spread to the lymph nodes, treat high-risk cancers along with other treatments, such as surgery, treat SCC that comes back after treatment, help relieve or control symptoms (called palliative therapy). […] Drug therapy uses drugs to treat SCC. The type of drug therapy used depends on where the cancer is located. […] Topical therapy is given as a cream or ointment that contains drugs and is applied on the skin. It may be offered to treat SCC in situ. In some cases, topical therapy is used for low-risk SCC.
  • #17 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    Curettage and electrodesiccation: This approach might be useful in treating some small, thin SCCs that have a low risk of coming back, but its not usually used for larger tumors. […] Standard excision: This type of surgery, in which the tumor and a margin of normal skin around it are removed, is often used to treat SCCs. […] Mohs surgery is especially useful for SCCs that are at higher risk for coming back, such as larger tumors, tumors with poorly defined edges, cancers that have come back after other treatments, cancers that are spreading along nerves under the skin, and cancers on certain areas of the face or genital area. […] Radiation therapy might be an option for people with large SCCs, especially for tumors in areas where surgery would be hard to do (such as the eyelids, ears, or nose), or for people who cant have (or dont want) surgery.
  • #18 Squamous cell carcinoma
    https://www.christie.nhs.uk/patients-and-visitors/your-treatment-and-care/types-of-cancer/squamous-cell-carcinoma
    Most people with a squamous cell carcinoma can be completely cured with simple treatment. […] Surgery is usually the recommended treatment. This involves removing the lesion with a margin of normal skin around it, usually using local anaesthetic. The skin is then closed with some stitches or sometimes a skin graft is needed. […] Radiotherapy can also be used to treat SCC. This involves shining a beam of X-rays into the skin. Usually several sessions are required. For advanced SCC a combination of treatments may be used. If it has spread to other parts of the body, then surgery, radiotherapy and/or systemic anti-cancer treatment may be used.
  • #19 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Radiation therapy uses high-energy rays or particles to destroy cancer cells. You may be offered radiation therapy to: treat SCC that cant be removed with surgery or if surgery will change your appearance or how the area functions, treat SCC that could not be completely removed by surgery, after surgery to destroy cancer cells that have spread to the lymph nodes, treat high-risk cancers along with other treatments, such as surgery, treat SCC that comes back after treatment, help relieve or control symptoms (called palliative therapy). […] Drug therapy uses drugs to treat SCC. The type of drug therapy used depends on where the cancer is located. […] Topical therapy is given as a cream or ointment that contains drugs and is applied on the skin. It may be offered to treat SCC in situ. In some cases, topical therapy is used for low-risk SCC.
  • #20 Cutaneous Squamous Cell Carcinoma Treatment & Management: Approach Considerations, Electrodessication and Curettage, Surgical Excision
    https://emedicine.medscape.com/article/1965430-treatment
    Immunotherapy, especially with programmed death ligand 1 (PD-L1) inhibitors, may be considered in advanced cSCC. […] The PD-L1 inhibitor cemiplimab (Libtayo) became the first treatment specifically approved for patients with metastatic or locally advanced cSCC who are not candidates for curative surgery or curative radiation. […] Topical application of 5-FU or imiquimod is effective in treating precancerous skin lesions. […] Photodynamic therapy is used primarily to treat large numbers of actinic keratoses in a single session. SCCIS is also amenable to photodynamic therapy, although a wide range of recurrence rates (0-52%) has been reported.
  • #21 Guidelines of care for the management of cutaneous squamous cell carcinoma
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6652228/
    Surgical treatment Standard excision Mohs micrographic surgery Curettage and electrodesiccation Cryosurgery Topical therapy Fluorouracil Imiquimod Other Energy devices Laser Photodynamic therapy (MAL* and ALA) Radiation therapy What are effective treatment options for the management of advanced BCC and cSCC? Hedgehog inhibitors* What are the effective methods for follow-up and preventing recurrence and new primary keratinocyte cancer formation? Oral and topical retinoids Celecoxib -Difluoromethylornithine Selenium -Carotene. […] It is generally accepted that the majority of cSCCs are successfully treated with standard treatment modalities, such as surgical excision. However, there is a subset of tumors with increased risk for local recurrence, perineural spread, and even nodal or distant metastasis, particularly in immunocompromised individuals.
  • #22 Skin Cancer | Basal Cell Carcinoma | Squamous Cell | CancerCare
    https://www.cancercare.org/publications/418-treatment_update_basal_cell_and_squamous_cell_cancer
    At the time of diagnosis, most cases of BCC and SCC have not spread from their original locations and are managed with local treatments, including the use of topical medications (applied directly to the skin) such as fluorouracil (Efudex) or surgical removal of the tumor. […] If the tumor is removed surgically, the tissue is sent to a pathologist who checks to make sure the entire tumor was removed. In some cases, a second operation may be needed to remove more of the tumor. […] Imiquimod cream can be applied to the biopsy site of certain BCCs to treat any cancer cells that remain. This treatment is typically given 5 days a week for 6 weeks. The most common side effect is irritation at the site of application. […] There are certain superficial types of BCC and SCC that can be treated by performing small in-office procedures, including electrodessication and curettage (sometimes called scrape and burn) for BCC and two cycles of cryotherapy (freezing) for SCC.
  • #23 Guidelines of care for the management of cutaneous squamous cell carcinoma
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6652228/
    Surgical treatment Standard excision Mohs micrographic surgery Curettage and electrodesiccation Cryosurgery Topical therapy Fluorouracil Imiquimod Other Energy devices Laser Photodynamic therapy (MAL* and ALA) Radiation therapy What are effective treatment options for the management of advanced BCC and cSCC? Hedgehog inhibitors* What are the effective methods for follow-up and preventing recurrence and new primary keratinocyte cancer formation? Oral and topical retinoids Celecoxib -Difluoromethylornithine Selenium -Carotene. […] It is generally accepted that the majority of cSCCs are successfully treated with standard treatment modalities, such as surgical excision. However, there is a subset of tumors with increased risk for local recurrence, perineural spread, and even nodal or distant metastasis, particularly in immunocompromised individuals.
  • #24 Squamous Cell Carcinoma: What it is, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/17480-squamous-cell-carcinoma
    If you have invasive squamous cell carcinoma or if treatment to remove your cancer surgically isn’t right for you, your healthcare provider could offer medicine to treat your diagnosis. Medicines could include: Skin creams containing imiquimod or 5-fluorouracil help treat squamous cell carcinoma that’s in the top layer of your skin (epidermis). Cemiplimab-rwlc (Libtayo) is immunotherapy to treat advanced forms of squamous cell carcinoma. Pembrolizumab (Keytruda) is immunotherapy to treat squamous cell carcinoma that isn’t treatable with surgery. […] The most common side effect of squamous cell carcinoma treatment is cosmetic changes to your skin, like scarring, after your healthcare provider removes the cancer from your body. […] The amount of time your body needs to heal after treatment varies for each person. The size shape and location also affect your healing time after treatment. On average, most people will recover within two to four weeks after treatment to remove cancer from their body. Your healthcare provider will meet with you a few weeks after treatment to make sure your body is healing properly and to make sure treatment was successful at removing cancer.
  • #25 Skin Cancer | Basal Cell Carcinoma | Squamous Cell | CancerCare
    https://www.cancercare.org/publications/418-treatment_update_basal_cell_and_squamous_cell_cancer
    Mohs micrographic surgery, a precise surgical technique, is often used to treat BCC and SCC that appears on the head and neck. This is a skin-sparing technique, in which pieces of skin are progressively removed at the site of the tumor and examined under a microscope until only cancer-free tissue remains. […] If surgery is not an option, radiation may be considered. Radiation may also be used after surgery if there is concern about the risk of the skin cancer recurring (coming back). […] In advanced cases of BCC and SCC, surgery or radiation may not be an option. In these situations, immunotherapies or targeted therapies are often prescribed. […] Immunotherapies are treatments that take advantage of the body’s immune system to fight cancer. These treatments are often administered intravenously (into a vein). Targeted therapy focuses on specific molecules and cell mechanisms thought to be important for cancer cell survival and growth, taking advantage of what researchers have learned in recent years about how cancer cells grow. Some targeted therapies are given in pill form; others are given intravenously.
  • #26 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. The immunotherapy drugs that may be used for SCC are: cemiplimab (Libtayo), pembrolizumab (Keytruda). […] Targeted therapy uses drugs to target specific molecules (such as proteins) on or inside cancer cells to stop the growth and spread of cancer cells. The targeted therapy drug used for SCC is cetuximab (Erbitux). […] Systemic chemotherapy is not usually offered for SCC. But it may be used for metastatic SCC. The most common chemotherapy drug used is cisplatin. It is given intravenously. It can be used alone or combined with other drugs in some cases, including the immunotherapy drug called interferon and retinoid drugs. […] You may be offered photodynamic therapy (PDT) for SCC in situ. It uses a light-sensitive drug (photosensitizer) and a special type of light to destroy cancer cells.
  • #27 Squamous Cell Carcinoma: Diagnosis & Treatment | NewYork-Presbyterian
    https://www.nyp.org/cancer/skin-cancer/squamous-cell-cancer/treatment
    Your doctor may use cryosurgeryfreezing the cancer cells with liquid nitrogento treat squamous cell carcinoma that has not invaded deeply into the skin. […] This approach treats some superficial squamous cell carcinomas and actinic keratosis (precancers). Your doctor applies a cream containing a chemical activated by an intense blue ultraviolet light. When they direct the light at cancer, the chemical selectively destroys squamous cell cancer cells while causing minimal damage to nearby healthy skin tissue. […] Radiation is used to treat some large or oddly situated squamous cell carcinomas. Your doctor may use it after surgery to kill any remaining cancer cells. […] Our team of expert dermatologists, dermatopathologists, medical oncologists, and radiation oncologists provide advanced care for squamous cell carcinoma and other skin cancers.
  • #28 Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/scc-treatment-options/
    For small, early SCCs that have not spread, excisional surgery is frequently the only treatment required. […] Mohs surgery is the most effective technique for removing SCCs, sparing the greatest amount of healthy tissue while achieving the highest possible cure rate – up to 97 percent for tumors treated for the first time. […] Curettage and electrodesiccation can be effective for most small, superficial or minimally invasive SCCs. […] Cryosurgery is effective for superficial SCCs, especially for patients with bleeding disorders, implantable cardiac devices or problems tolerating anesthesia. […] Laser surgery is not yet FDA-approved for SCC but is sometimes used for superficial SCCs, especially when other techniques have been unsuccessful. […] Radiation therapy is primarily used for SCCs that are hard to treat surgically, and in elderly patients or people in poor health for whom surgery is not advised. […] PDT can be used for some superficial SCCs on the face and scalp but is not recommended for invasive SCCs. […] While these topical medications are not yet FDA-approved for treating SCCs, they are sometimes used for superficial tumors.
  • #29 Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
    Surgical excision is still the gold standard and includes conventional and Mohs surgery. Conventional excision must ensure complete removal and therefore include a margin of clinically normal-appearing skin around the tumor and surrounding erythema. […] NCCN guidelines recommend 4- to 6-mm clinical margins for standard excision of low-risk SCC, whereas Mohs surgery is recommended in high-risk SCC, SCC in immunocompromised patients, or special-site SCC such as head and neck, where tissue conservation is important. […] If surgical therapy is not feasible or elected, nonsurgical local approaches may be considered. For in situ or low-risk SCC, the physician can choose photodynamic therapy, or topical therapy with imiquimod, or 5-fluorouracil. […] High-risk SCC should always be surgically excised, preferably by Mohs technique; however, adjuvant radiation therapy to the local tumor site following surgical treatment may be considered in primary SCC concerning perineural invasion or at high risk for regional or distant metastasis.
  • #30 Advanced Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/advanced-scc/
    About 95 percent of squamous cell carcinomas (SCCs) of the skin are detected early, when they are easiest to treat and cure. The remaining 5 percent of SCC cases have advanced to such an extent that they are far more dangerous and challenging to treat. […] Fortunately, the field of immunotherapy is growing, giving patients with advanced SCC a new option for treating and managing the disease. […] If you’ve been diagnosed with advanced SCC, your doctor may recommend an evaluation by a multidisciplinary team to explore treatment options. The team may include your dermatologist and/or Mohs surgeon, along with physicians and surgeons from other specialties. […] After surgery to remove the tumor and, if necessary due to metastasis, local lymph nodes, options may include a combination of treatments, based on the complexity of the disease and your overall health. The regimen can include: Excisional surgery, Mohs surgery, Radiation, Immunotherapy.
  • #31 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    Radiation is sometimes used after surgery (standard excision or lymph node dissection) if all of the cancer was not removed (if the surgical margins were positive), if nerves are involved, or if there is a chance that some cancer may still be left. […] Cryotherapy (cryosurgery) might be an option for some early squamous cell cancers that are at low risk for coming back, especially in people who cant have surgery, but its typically not recommended for larger SCCs or those on certain parts of the nose, ears, eyelids, scalp, or legs. […] Treatment options for SCC that remains after treatment or that comes back later depend on where the tumor is, what the first treatment was, and other factors. […] If possible, surgery (such as Mohs surgery or a re-excision) is often recommended to try to remove any remaining cancer.
  • #32 Squamous Cell Carcinoma: What it is, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/17480-squamous-cell-carcinoma
    If you have invasive squamous cell carcinoma or if treatment to remove your cancer surgically isn’t right for you, your healthcare provider could offer medicine to treat your diagnosis. Medicines could include: Skin creams containing imiquimod or 5-fluorouracil help treat squamous cell carcinoma that’s in the top layer of your skin (epidermis). Cemiplimab-rwlc (Libtayo) is immunotherapy to treat advanced forms of squamous cell carcinoma. Pembrolizumab (Keytruda) is immunotherapy to treat squamous cell carcinoma that isn’t treatable with surgery. […] The most common side effect of squamous cell carcinoma treatment is cosmetic changes to your skin, like scarring, after your healthcare provider removes the cancer from your body. […] The amount of time your body needs to heal after treatment varies for each person. The size shape and location also affect your healing time after treatment. On average, most people will recover within two to four weeks after treatment to remove cancer from their body. Your healthcare provider will meet with you a few weeks after treatment to make sure your body is healing properly and to make sure treatment was successful at removing cancer.
  • #33 Skin cancer types: Squamous cell carcinoma treatment
    https://www.aad.org/diseases/skin-cancer/squamous-cell-carcinoma-treatment
    Cryosurgery: This treatment involves using an extremely cold substance, such as liquid nitrogen, to destroy the cancer cells. […] Immunotherapy: This type of treatment works with your body’s immune system to fight cancer. Immunotherapy helps some people with advanced cancer live longer. […] Chemotherapy: This treatment can help slow spreading cancer and relieve symptoms. Sometimes, chemotherapy shrinks tumors. […] When found early, this cancer is highly treatable. Left untreated, however, the cancer can spread deep into the skin and travel to other parts of the body, making treatment difficult.
  • #34 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. The immunotherapy drugs that may be used for SCC are: cemiplimab (Libtayo), pembrolizumab (Keytruda). […] Targeted therapy uses drugs to target specific molecules (such as proteins) on or inside cancer cells to stop the growth and spread of cancer cells. The targeted therapy drug used for SCC is cetuximab (Erbitux). […] Systemic chemotherapy is not usually offered for SCC. But it may be used for metastatic SCC. The most common chemotherapy drug used is cisplatin. It is given intravenously. It can be used alone or combined with other drugs in some cases, including the immunotherapy drug called interferon and retinoid drugs. […] You may be offered photodynamic therapy (PDT) for SCC in situ. It uses a light-sensitive drug (photosensitizer) and a special type of light to destroy cancer cells.
  • #35 Cutaneous Squamous Cell Carcinoma Treatment & Management: Approach Considerations, Electrodessication and Curettage, Surgical Excision
    https://emedicine.medscape.com/article/1965430-treatment
    Immunotherapy, especially with programmed death ligand 1 (PD-L1) inhibitors, may be considered in advanced cSCC. […] The PD-L1 inhibitor cemiplimab (Libtayo) became the first treatment specifically approved for patients with metastatic or locally advanced cSCC who are not candidates for curative surgery or curative radiation. […] Topical application of 5-FU or imiquimod is effective in treating precancerous skin lesions. […] Photodynamic therapy is used primarily to treat large numbers of actinic keratoses in a single session. SCCIS is also amenable to photodynamic therapy, although a wide range of recurrence rates (0-52%) has been reported.
  • #36 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    If the cancer comes back in nearby lymph nodes or in other parts of the body, systemic treatments such as immunotherapy or chemotherapy drugs might be an option. […] Different types of treatments might be used for SCCs that have spread beyond the skin. […] For advanced SCCs that cant be cured with surgery or radiation therapy, one option might be using an immunotherapy drug such as cemiplimab (Libtayo), pembrolizumab (Keytruda), or cosibelimab (Unloxcyt). […] Chemotherapy and targeted therapy drugs (EGFR inhibitors) might be other options for people with SCC that has spread to lymph nodes or distant organs.
  • #37 Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
    Regarding locally advanced and metastatic SCC, treatment is based on the extent of disease. If lymph nodes are involved, dissection must be performed whenever possible, and adjuvant radiation with or without concurrent systemic therapy must be considered. […] Systemic therapies such as capecitabine or epidermal growth factor receptor inhibitors have demonstrated efficacy in patients with advanced, unresectable SCC. […] Based on the high mutational loads of SCC, the well-known infiltration with lymphocytes, and programmed death ligand 1 (PD-L1) expression, there is a promising utility in treating SCC with the immune checkpoint inhibitors such as pembrolizumab. […] Recently the first anti-PD1 drug cemiplimab was approved by the US Food and Drug Administration after having demonstrated responses in about 50% of advanced or metastatic SCC.
  • #38 Advanced Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/advanced-scc/
    For small, early SCCs that have not spread, excisional surgery is frequently the only treatment required. For advanced SCCs, the physician will most likely recommend additional treatments following removal of the tumor. […] Mohs surgery is the most effective technique for removing early SCCs and is also used for SCC tumors that have recurred, are large or growing rapidly or have indistinct edges. […] Radiation therapy is primarily used for SCCs that are hard to treat surgically, and in elderly patients or people in poor health for whom surgery is not advised. […] In September 2018, after successful clinical trials, the immunotherapy, cemiplimab-rwlc (Libtayo®), became the first medication of any kind to be approved by the U.S. Food and Drug Administration (FDA) for treating patients with certain forms of advanced cutaneous squamous cell carcinoma.
  • #39 Skin Cancer | Basal Cell Carcinoma | Squamous Cell | CancerCare
    https://www.cancercare.org/publications/418-treatment_update_basal_cell_and_squamous_cell_cancer
    The targeted therapy cetuximab (Erbitux) is sometimes prescribed to treat people whose SCC tumors cannot be surgically removed or treated with radiation. By attaching to a structure on the cell called the epidermal growth factor receptor (EGFR), cetuximab can block one of the signals that tells a tumor to grow.
  • #40 Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
    Regarding locally advanced and metastatic SCC, treatment is based on the extent of disease. If lymph nodes are involved, dissection must be performed whenever possible, and adjuvant radiation with or without concurrent systemic therapy must be considered. […] Systemic therapies such as capecitabine or epidermal growth factor receptor inhibitors have demonstrated efficacy in patients with advanced, unresectable SCC. […] Based on the high mutational loads of SCC, the well-known infiltration with lymphocytes, and programmed death ligand 1 (PD-L1) expression, there is a promising utility in treating SCC with the immune checkpoint inhibitors such as pembrolizumab. […] Recently the first anti-PD1 drug cemiplimab was approved by the US Food and Drug Administration after having demonstrated responses in about 50% of advanced or metastatic SCC.
  • #41 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. The immunotherapy drugs that may be used for SCC are: cemiplimab (Libtayo), pembrolizumab (Keytruda). […] Targeted therapy uses drugs to target specific molecules (such as proteins) on or inside cancer cells to stop the growth and spread of cancer cells. The targeted therapy drug used for SCC is cetuximab (Erbitux). […] Systemic chemotherapy is not usually offered for SCC. But it may be used for metastatic SCC. The most common chemotherapy drug used is cisplatin. It is given intravenously. It can be used alone or combined with other drugs in some cases, including the immunotherapy drug called interferon and retinoid drugs. […] You may be offered photodynamic therapy (PDT) for SCC in situ. It uses a light-sensitive drug (photosensitizer) and a special type of light to destroy cancer cells.
  • #42 Medications for Basal & Squamous Cell Skin Cancers | NYU Langone Health
    https://nyulangone.org/conditions/basal-squamous-cell-skin-cancers/treatments/medications-for-basal-squamous-cell-skin-cancers
    Managing Side Effects: Muscle cramps, skin rash, fatigue, decreased appetite, diarrhea, nausea, and vomiting are some of the side effects associated with the medications used to treat advanced basal and squamous cell cancers. Doctors can adjust the dose of these medications, substitute others, or prescribe integrative health therapies to help manage side effects. […] Clinical Trials: NYU Langone researchers are conducting clinical trials of different medications for advanced basal cell and squamous cell cancers. Your doctor can help you decide if a clinical trial is right for you. […] In a clinical trial, doctors may prescribe medications called epidermal growth factor receptor inhibitors to improve a squamous cell cancers response to chemotherapy. Squamous cell tumors can contain high levels of a protein called epidermal growth factor receptor. This protein signals cancer cells to grow and divide. […] Medications that interfere with their action include cetuximab, which is given by IV infusion, or erlotinib, which is taken by mouth each day.
  • #43 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. The immunotherapy drugs that may be used for SCC are: cemiplimab (Libtayo), pembrolizumab (Keytruda). […] Targeted therapy uses drugs to target specific molecules (such as proteins) on or inside cancer cells to stop the growth and spread of cancer cells. The targeted therapy drug used for SCC is cetuximab (Erbitux). […] Systemic chemotherapy is not usually offered for SCC. But it may be used for metastatic SCC. The most common chemotherapy drug used is cisplatin. It is given intravenously. It can be used alone or combined with other drugs in some cases, including the immunotherapy drug called interferon and retinoid drugs. […] You may be offered photodynamic therapy (PDT) for SCC in situ. It uses a light-sensitive drug (photosensitizer) and a special type of light to destroy cancer cells.
  • #44 Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
    Regarding locally advanced and metastatic SCC, treatment is based on the extent of disease. If lymph nodes are involved, dissection must be performed whenever possible, and adjuvant radiation with or without concurrent systemic therapy must be considered. […] Systemic therapies such as capecitabine or epidermal growth factor receptor inhibitors have demonstrated efficacy in patients with advanced, unresectable SCC. […] Based on the high mutational loads of SCC, the well-known infiltration with lymphocytes, and programmed death ligand 1 (PD-L1) expression, there is a promising utility in treating SCC with the immune checkpoint inhibitors such as pembrolizumab. […] Recently the first anti-PD1 drug cemiplimab was approved by the US Food and Drug Administration after having demonstrated responses in about 50% of advanced or metastatic SCC.
  • #45 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    If the cancer comes back in nearby lymph nodes or in other parts of the body, systemic treatments such as immunotherapy or chemotherapy drugs might be an option. […] Different types of treatments might be used for SCCs that have spread beyond the skin. […] For advanced SCCs that cant be cured with surgery or radiation therapy, one option might be using an immunotherapy drug such as cemiplimab (Libtayo), pembrolizumab (Keytruda), or cosibelimab (Unloxcyt). […] Chemotherapy and targeted therapy drugs (EGFR inhibitors) might be other options for people with SCC that has spread to lymph nodes or distant organs.
  • #46 Treatment Options for Squamous Cell Carcinoma
    https://www.pharmacytimes.com/view/treatment-options-for-squamous-cell-carcinoma
    Cutaneous squamous cell carcinoma should be diagnosed early and treated promptly to avoid complications. […] Nonpharmaceutical treatment options for small SCC cancers may include curettage and electrodesiccation, laser therapy, freezing, or photodynamic therapy. Treatments for CSCC in larger areas may include removal of the affected area, Mohs surgery, or radiation therapy. […] Medications approved for SCC include cemiplimab (Libtayo; Regeneron and Sanofi) and pembrolizumab (Keytruda; Merck). […] Treatment of SCC with cemiplimab may include 350 mg given intravenously over 30 minutes every 3 weeks until disease progression or unacceptable toxicity. […] Pembrolizumab dosing for the treatment of SCC is 200 mg intravenously over 30 minutes every 3 weeks or 400 mg intravenously over 30 minutes every 6 weeks until disease progression stops, unacceptable toxicity, or up to 24 months of therapy.
  • #47 Cutaneous Squamous Cell Carcinoma Treatment & Management: Approach Considerations, Electrodessication and Curettage, Surgical Excision
    https://emedicine.medscape.com/article/1965430-treatment
    Immunotherapy, especially with programmed death ligand 1 (PD-L1) inhibitors, may be considered in advanced cSCC. […] The PD-L1 inhibitor cemiplimab (Libtayo) became the first treatment specifically approved for patients with metastatic or locally advanced cSCC who are not candidates for curative surgery or curative radiation. […] Topical application of 5-FU or imiquimod is effective in treating precancerous skin lesions. […] Photodynamic therapy is used primarily to treat large numbers of actinic keratoses in a single session. SCCIS is also amenable to photodynamic therapy, although a wide range of recurrence rates (0-52%) has been reported.
  • #48 Treatment for Squamous Cell Carcinoma | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/squamous-cell-carcinoma/treatment-squamous-cell-carcinoma
    Most cases of squamous cell carcinoma can be cured when found early and treated properly. […] Today, many treatment options are available, and most are easily performed at a doctors office. […] Which treatment approach is best for you will depend on such things as whether the squamous cell skin cancer is high risk or low risk, and your age, general health, medical history, and personal preferences. […] Its important not to delay treatment for too long, since this can make the cancer more difficult to cure. […] At Memorial Sloan Kettering, our experts treat squamous cell skin cancer with surgery, radiation therapy, or topical chemotherapy in some cases. […] Surgery is often recommended to remove squamous cell lesions, particularly those classified as high risk. […] Mohs surgery has the highest cure rate of all therapies for squamous cell carcinomas.
  • #49 Squamous cell carcinoma of the skin – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/diagnosis-treatment/drc-20352486
    Most squamous cell carcinomas of the skin can be removed with minor surgery. Some are removed with a medicine applied to the skin. The treatment depends on where the cancer is, how large it is, how fast it’s growing and what you prefer. […] If the skin cancer is small, not deep into the skin, called superficial, and has a low risk of spreading, less-invasive treatment choices include: […] More-invasive treatments might be recommended for larger squamous cell carcinomas and those that go deeper into the skin. Options might include: […] When squamous cell carcinoma spreads to other parts of the body, medicines might be recommended, including: […] For squamous cell carcinoma of the skin, immunotherapy might be considered when the cancer is advanced and other treatments aren’t an option.
  • #50 Advanced Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/advanced-scc/
    About 95 percent of squamous cell carcinomas (SCCs) of the skin are detected early, when they are easiest to treat and cure. The remaining 5 percent of SCC cases have advanced to such an extent that they are far more dangerous and challenging to treat. […] Fortunately, the field of immunotherapy is growing, giving patients with advanced SCC a new option for treating and managing the disease. […] If you’ve been diagnosed with advanced SCC, your doctor may recommend an evaluation by a multidisciplinary team to explore treatment options. The team may include your dermatologist and/or Mohs surgeon, along with physicians and surgeons from other specialties. […] After surgery to remove the tumor and, if necessary due to metastasis, local lymph nodes, options may include a combination of treatments, based on the complexity of the disease and your overall health. The regimen can include: Excisional surgery, Mohs surgery, Radiation, Immunotherapy.
  • #51 Squamous cell carcinoma of the skin – Care at Mayo Clinic – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/care-at-mayo-clinic/mac-20352488
    Mayo Clinic specialists provide expert care for people with squamous cell carcinoma of the skin. […] At Mayo Clinic, skin specialists (dermatologists) work with other experts in medical oncology, radiation oncology, pathology, surgery, and plastic and reconstructive surgery to provide comprehensive care for those with squamous cell carcinoma of the skin. Other professionals are included as needed. […] Mayo Clinic doctors work with you to review all treatment options and choose the treatment that best suits your needs and goals. […] The range of treatments for squamous cell carcinoma of the skin includes many types of procedures to remove skin cancer. These include local excision, Mohs surgery, laser treatment, cryosurgery, and curettage and electrodessication. Other treatment options include photodynamic therapy, radiation therapy, and chemotherapy and other medicines.
  • #52 Treatments for squamous cell carcinoma | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/skin-non-melanoma/treatment/squamous-cell-carcinoma
    Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. The immunotherapy drugs that may be used for SCC are: cemiplimab (Libtayo), pembrolizumab (Keytruda). […] Targeted therapy uses drugs to target specific molecules (such as proteins) on or inside cancer cells to stop the growth and spread of cancer cells. The targeted therapy drug used for SCC is cetuximab (Erbitux). […] Systemic chemotherapy is not usually offered for SCC. But it may be used for metastatic SCC. The most common chemotherapy drug used is cisplatin. It is given intravenously. It can be used alone or combined with other drugs in some cases, including the immunotherapy drug called interferon and retinoid drugs. […] You may be offered photodynamic therapy (PDT) for SCC in situ. It uses a light-sensitive drug (photosensitizer) and a special type of light to destroy cancer cells.
  • #53 Treating Squamous Cell Carcinoma | Squamous Cell Cancer Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating/squamousl-cell-carcinoma.html
    Radiation is sometimes used after surgery (standard excision or lymph node dissection) if all of the cancer was not removed (if the surgical margins were positive), if nerves are involved, or if there is a chance that some cancer may still be left. […] Cryotherapy (cryosurgery) might be an option for some early squamous cell cancers that are at low risk for coming back, especially in people who cant have surgery, but its typically not recommended for larger SCCs or those on certain parts of the nose, ears, eyelids, scalp, or legs. […] Treatment options for SCC that remains after treatment or that comes back later depend on where the tumor is, what the first treatment was, and other factors. […] If possible, surgery (such as Mohs surgery or a re-excision) is often recommended to try to remove any remaining cancer.
  • #54 Squamous cell carcinoma (SCC) – symptoms, diagnosis and treatment | healthdirect
    https://www.healthdirect.gov.au/squamous-cell-carcinoma
    Squamous cell carcinoma (SCC) is a common type of skin cancer that occurs on your skin in places where you’ve been exposed to sun. […] It’s usually possible for a doctor to completely remove your SCC. […] The best type of treatment for you will depend on the size and location of your SCC. […] Usually, the doctor will remove your SCC using simple skin surgery. They will then look at the area under a microscope to check all the cancer has been removed. If it has spread, you might need radiotherapy afterwards. […] Other ways of removing the SCC are: scraping it off then sealing the base of the wound with an electric needle or liquid nitrogen, freezing it off. […] After treatment, you will need follow-up appointments with your doctor. You will be at greater risk of developing another skin cancer, so it’s more important than ever to protect your skin from the sun. […] If your SCC has spread, you may be treated with an immunotherapy medicine given into your vein called cemiplimab.
  • #55 Cutaneous Squamous Cell Carcinoma
    https://www.aad.org/member/clinical-quality/guidelines/scc
    Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human skin cancer with at least 200,000 to 400,000 new cases of cSCC expected each year in the US. These evidence-based guidelines on the management of cSCC provide the most current information on biopsy techniques, histopathologic assessment, tumor staging, surgical and nonsurgical treatments, follow-up, prevention of recurrence, and management of advanced disease. […] In general, surgical therapy remains the most effective treatment for cSCC. […] Nonsurgical therapies (radiation therapy, cryosurgery) may be selected for low-risk tumors or if surgery is contraindicated, with the understanding that the cure rate may be lower. […] As there are limited treatment options for metastatic disease, early and complete treatment is important. […] Patients diagnosed with cSCC should have annual checks for recurrence or other new primary skin cancer(s).
  • #56 Spot Check | Squamous cell carcinoma
    https://www.spotcheck.clinic/conditions/skin-cancers/scc/
    A plastic surgeon can perform a wide excision of a squamous cell carcinoma to achieve a good cosmetic outcome or preserve function of the affected area. […] A public hospital dermatology unit can offer a team approach where surgeons, dermatologists, oncologists skin pathologists and other specialties are involved in your care. This may be required if you have a high-risk squamous cell carcinoma with signs of perineural spread or other microscopic warning signs. […] Regular skin checks will help detect evidence of the cancer returning and allow detection of new skin cancers. […] Treating solar keratoses may reduce the risk of SCC. Treatment options include cryotherapy (freezing) of individual solar keratoses and prescription creams, photodynamic therapy or fractional laser treatment of larger areas.
  • #57 Spot Check | Squamous cell carcinoma
    https://www.spotcheck.clinic/conditions/skin-cancers/scc/
    Daily use of sunscreen significantly reduces the risk of squamous cell carcinoma in people who have already had one. […] Vitamin B3 (taken in the form of nicotinamide 1000mg daily) reduces the development of future squamous and basal cell carcinomas by 23 per cent. […] There are case studies of HPV vaccine being successfully used to treat and prevent the recurrence of SCC in patients unsuitable for surgical treatment. […] Excision or excision biopsy is a procedure where a doctor cuts around a skin lesion through the full thickness of skin, usually closing the resulting hole with stitches. […] Cryotherapy destroys cells by freezing them. It is useful for treating shallow and flat skin lesions such as superficial skin cancers, solar keratoses, lentigines and some seborrhoeic keratoses.
  • #58 Treating Basal & Squamous Cell Skin Cancer | Squamous Cell Treatment | American Cancer Society
    https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating.html
    Most basal and squamous cell cancers (as well as pre-cancers) are treated by dermatologists doctors who specialize in treating skin diseases. […] In some situations, such as if the cancer is more advanced, you may be treated by other types of doctors as well, such as: A surgical oncologist: a doctor who treats cancer with surgery, A medical oncologist: a doctor who treats cancer with chemotherapy or other medicines, A radiation oncologist: a doctor who treats cancer with radiation therapy. […] Its important to discuss all of your treatment options, including their goals and possible side effects, with your doctors to help make the decision that best fits your needs. […] Clinical trials are carefully controlled research studies that are done to get a closer look at promising new treatments or procedures. Clinical trials are one way to get state-of-the-art cancer treatment.
  • #59 Immunotherapy for Skin Cancer – Cancer Research Institute
    https://www.cancerresearch.org/cancer-types/skin-cancer
    Immunotherapy for skin cancer provides treatment options for patients with advanced cases. […] While immunotherapy has been successful in melanoma and cutaneous squamous cell carcinoma, new treatment options for these and other skin cancers are urgently needed. […] Early-stage skin cancers that remain localized are often successfully treated through a variety of surgical techniques as well as radiation therapy, photodynamic therapy, and topical chemotherapy. For advanced cases beyond surgery, there are several chemotherapies and immunotherapies available for patients. […] Immunotherapy is a class of treatments that take advantage of a person’s own immune system to help kill cancer cells. There are currently twelve FDA-approved immunotherapy options for skin cancer. […] These checkpoint immunotherapy approvals were landmark events for the treatment of certain skin cancers. While the vast majority of cases of early-stage, non-melanoma skin cancer are successfully treated by dermatologists in an outpatient setting, those who have advanced disease that doesn’t respond to traditional treatment may want to consider clinical trials in which promising immunotherapy strategies are currently being evaluated.
  • #60 Immunotherapy for Skin Cancer – Cancer Research Institute
    https://www.cancerresearch.org/cancer-types/skin-cancer
    CRI CLIP Investigator John Carucci, MD, PhD, discovered that blocking the activity of the JAK/STAT pathway reduces the growth of suppression-associated squamous cell carcinoma (SCC) tumors in mice, thus providing a potential strategy through which cancer patients who have also received organ transplants could be treated without compromising the tolerance of their transplants. […] Poly ICLC (Hiltonol®): an immune adjuvant targeting the Toll-like receptor 3 (TLR3) pathway; approved for subsets of patients with squamous cell carcinoma.
  • #61 Skin Cancer Tx | Fractional Laser – Dr Bruce Robinson
    https://brucerobinsonmd.com/fractional-laser-treatment-for-skin-cancer-basal-cell-carcinoma-squamous-cell-carcinoma/
    Bruce Robinson, MD is pioneering a transformative new treatment option for the most common forms of skin cancer: Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). […] It involves a combination of Fractional Laser therapy and topical medication. The results have been dramatic: almost complete elimination of BCCs and SCCs, requiring only ONE very short treatment, with minimal disruption for the patient, and an excellent visual end result. […] The use of fractional lasers to wipe out BCCs or SCCs promises to open a whole new chapter in skin cancer treatment, and Dr. Robinson is expanding his research and healing in this area. […] Since 2023 Bruce Robinson, MD has been pioneering a new approach using fractional lasers on the skin followed by topical medication. With this combination he has achieved remarkable results, including a cancer clearing rate approaching 100% upon follow-up visits.
  • #62 Skin Cancer Tx | Fractional Laser – Dr Bruce Robinson
    https://brucerobinsonmd.com/fractional-laser-treatment-for-skin-cancer-basal-cell-carcinoma-squamous-cell-carcinoma/
    Dr. Robinsons unique approach combines Fractional Laser therapy alongside proven topical medication. […] The non-ablative fractional laser promises to be a new and innovative approach to skin cancer treatment without excision or stitches, risk of infection, physical limitations, or prolonged recovery time. […] In summary, fractional laser therapy emerges as a highly effective, safe, and patient-friendly approach to treating Basal and Squamous Cell Carcinomas. Its non-invasive nature, quick healing, minimal scarring, and efficacy in preventing recurrences make it an valuable option for a diverse range of patients seeking effective and aesthetically pleasing skin cancer treatment. […] The fractional laser, a tool typically employed for skin resurfacing to enhance appearance, has found a groundbreaking application in the hands of Dr. Robinson for the treatment of Basal and Squamous Cell Carcinomas.
  • #63 Skin Cancer Tx | Fractional Laser – Dr Bruce Robinson
    https://brucerobinsonmd.com/fractional-laser-treatment-for-skin-cancer-basal-cell-carcinoma-squamous-cell-carcinoma/
    The decision to opt for fractional laser treatment was rooted in its ability to offer numerous advantages over traditional surgical methods. The most striking benefit was the efficiency and convenience it brought to someone like RL, whose mobility challenges made traditional procedures nearly impossible.
  • #64 Squamous Cell Carcinoma Treatment
    https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/scc-treatment-options/
    Most squamous cell carcinomas (SCCs) of the skin can be cured when found and treated early. Treatment should happen as soon as possible after diagnosis, since more advanced SCCs of the skin are more difficult to treat and can become dangerous, spreading to local lymph nodes, distant tissues and organs. […] If you’ve been diagnosed with an SCC that has not spread (in situ), there are several effective treatments that can usually be performed on an outpatient basis. The choices available to you depend on the tumor type, size, location and depth, as well as your age and overall health. […] Options include: Excisional surgery, Mohs surgery, Cryosurgery, Curettage and electrodesiccation (electrosurgery), Laser surgery, Radiation, Photodynamic therapy (PDT), Topical medications. […] Ask your dermatologist to clearly explain the options that might work best for you, including details about the risks and benefits.
  • #65 Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
    Squamous cell carcinoma (SCC) accounts for most nonmelanoma skin cancerrelated metastatic disease and deaths. Histopathology and correct surgical excision remain the gold standard for the diagnosis and treatment of SCC; however, new diagnostic imaging techniques such as dermoscopy and reflectance confocal microscopy have increased the diagnostic accuracy in terms of early recognition, better differential diagnosis, more precise selection of areas to biopsy, and noninvasive monitoring of treatments. […] The therapeutic intervention in patients with severe actinic damage and multiple in situ/low-risk SCC, and the development of innovative treatments such as epidermal growth factor receptor inhibitors and immune checkpoint inhibitors for locally advanced and metastatic SCC, are improving considerably the approach to the disease.
  • #66 Squamous cell carcinoma of the skin – Care at Mayo Clinic – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/care-at-mayo-clinic/mac-20352488
    Mayo Clinic specialists provide expert care for people with squamous cell carcinoma of the skin. […] At Mayo Clinic, skin specialists (dermatologists) work with other experts in medical oncology, radiation oncology, pathology, surgery, and plastic and reconstructive surgery to provide comprehensive care for those with squamous cell carcinoma of the skin. Other professionals are included as needed. […] Mayo Clinic doctors work with you to review all treatment options and choose the treatment that best suits your needs and goals. […] The range of treatments for squamous cell carcinoma of the skin includes many types of procedures to remove skin cancer. These include local excision, Mohs surgery, laser treatment, cryosurgery, and curettage and electrodessication. Other treatment options include photodynamic therapy, radiation therapy, and chemotherapy and other medicines.
  • #67 Guidelines of care for the management of cutaneous squamous cell carcinoma
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6652228/
    Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. […] The treatment of cSCC has long been a substantial component of the clinical practice of dermatologists, who are well versed in the numerous available therapeutic options. These clinical practice guidelines provide evidence-based recommendations for clinical treatment and management of patients with cSCC. Information pertaining to widely utilized therapies, ranging from curettage and electrodesiccation (CE) to Mohs micrographic surgery (MMS), is reviewed. The quality of the evidence regarding emerging treatment modalities, such as topical and systemic medications and devices, is also discussed. Recommendations regarding staging, biopsy technique, prevention, and follow-up are made on the basis of the best available literature.
  • #68 Cutaneous Squamous Cell Carcinoma
    https://www.aad.org/member/clinical-quality/guidelines/scc
    Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human skin cancer with at least 200,000 to 400,000 new cases of cSCC expected each year in the US. These evidence-based guidelines on the management of cSCC provide the most current information on biopsy techniques, histopathologic assessment, tumor staging, surgical and nonsurgical treatments, follow-up, prevention of recurrence, and management of advanced disease. […] In general, surgical therapy remains the most effective treatment for cSCC. […] Nonsurgical therapies (radiation therapy, cryosurgery) may be selected for low-risk tumors or if surgery is contraindicated, with the understanding that the cure rate may be lower. […] As there are limited treatment options for metastatic disease, early and complete treatment is important. […] Patients diagnosed with cSCC should have annual checks for recurrence or other new primary skin cancer(s).
  • #69 Immunotherapy for Skin Cancer – Cancer Research Institute
    https://www.cancerresearch.org/cancer-types/skin-cancer
    Immunotherapy for skin cancer provides treatment options for patients with advanced cases. […] While immunotherapy has been successful in melanoma and cutaneous squamous cell carcinoma, new treatment options for these and other skin cancers are urgently needed. […] Early-stage skin cancers that remain localized are often successfully treated through a variety of surgical techniques as well as radiation therapy, photodynamic therapy, and topical chemotherapy. For advanced cases beyond surgery, there are several chemotherapies and immunotherapies available for patients. […] Immunotherapy is a class of treatments that take advantage of a person’s own immune system to help kill cancer cells. There are currently twelve FDA-approved immunotherapy options for skin cancer. […] These checkpoint immunotherapy approvals were landmark events for the treatment of certain skin cancers. While the vast majority of cases of early-stage, non-melanoma skin cancer are successfully treated by dermatologists in an outpatient setting, those who have advanced disease that doesn’t respond to traditional treatment may want to consider clinical trials in which promising immunotherapy strategies are currently being evaluated.
  • #70 Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
    Regarding locally advanced and metastatic SCC, treatment is based on the extent of disease. If lymph nodes are involved, dissection must be performed whenever possible, and adjuvant radiation with or without concurrent systemic therapy must be considered. […] Systemic therapies such as capecitabine or epidermal growth factor receptor inhibitors have demonstrated efficacy in patients with advanced, unresectable SCC. […] Based on the high mutational loads of SCC, the well-known infiltration with lymphocytes, and programmed death ligand 1 (PD-L1) expression, there is a promising utility in treating SCC with the immune checkpoint inhibitors such as pembrolizumab. […] Recently the first anti-PD1 drug cemiplimab was approved by the US Food and Drug Administration after having demonstrated responses in about 50% of advanced or metastatic SCC.